EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice

Erini Nessim Kostandy iD, Ji Ho Suh, Xiangjun Tian, Beanna Okeugo, Erin Rubin, Sara Shirai, Meng Luo, Christopher M Taylor iD, Kang Ho Kim, J Marc Rhoads iD, Yuying Liu iD

Nutrients · 2024

DOI: 10.3390/nu16040511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Erini Nessim Kostandy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Gastroenterology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, T…. Hauptthemen laut MEDLINE: Limosilactobacillus reuteri, Autoimmune Diseases, Probiotics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCCIH NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The probiotic Limosilactobacillus reuteri DSM 17938 produces anti-inflammatory effects in scurfy (SF) mice, a model characterized by immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (called IPEX syndrome in humans), caused by regulatory T cell (Treg) deficiency and is due to a Foxp3 gene mutation. Considering the pivotal role of lipids in autoimmune inflammatory processes, we investigated alterations in the relative abundance of lipid profiles in SF mice (± treatment with DSM 17938) compared to normal WT mice. We also examined the correlation between plasma lipids and gut microbiota and circulating inflammatory markers. We noted a significant upregulation of plasma lipids associated with autoimmune disease in SF mice, many of which were downregulated by DSM 17938. The upregulated lipids in SF mice demonstrated a significant correlation with gut bacteria known to be implicated in the pathogenesis of various autoimmune diseases. Chronic hepatitis in SF livers responded to DSM 17938 treatment with a reduction in hepatic inflammation. Altered gene expression associated with lipid metabolism and the positive correlation between lipids and inflammatory cytokines together suggest that autoimmunity leads to dyslipidemia with impaired fatty acid oxidation in SF mice. Probiotics are presumed to contribute to the reduction of lipids by reducing inflammatory pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Limosilactobacillus reuteriAutoimmune DiseasesProbioticsHumansMiceAnimalsT-Lymphocytes, RegulatoryHepatitis, ChronicLipidsForkhead Transcription Factors

Stichwörter der Autor:innen

IPEX syndromeautoimmune diseaseautoimmunityinflammationlipid metabolismmicrobiotaprobioticsregulatory T cellscurfy mouse

Substanzen

LipidsForkhead Transcription FactorsFoxp3 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Gastroenterology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Center, Houston, TX 77030, USA.
  • Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

ORCID-Profile: Erini Nessim Kostandy, Christopher M Taylor, J Marc Rhoads, Yuying Liu

Förderung

  • NIDDK NIH HHS
  • NCCIH NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health (NIH)/National Center for Complementary and Integrative Health (NCCIH)
  • NIH/National Institute of Allergy and Infectious Diseases (NIAID)
  • NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Texas Medical Center Digestive Diseases Center

Zitieren

APA

Nessim Kostandy, E., Suh, J. H., Tian, X., Okeugo, B., Rubin, E., Shirai, S., Luo, M., Taylor, C. M., Kim, K. H., Rhoads, J. M., & Liu, Y. (2024). Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice. Nutrients. https://doi.org/10.3390/nu16040511

Vancouver

Nessim Kostandy E, Suh JH, Tian X, Okeugo B, Rubin E, Shirai S, et al. Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice. Nutrients. 2024. doi:10.3390/nu16040511

BibTeX
@article{NessimKostandy2024,
  author = {Nessim Kostandy, Erini and Suh, Ji Ho and Tian, Xiangjun and Okeugo, Beanna and Rubin, Erin and Shirai, Sara and Luo, Meng and Taylor, Christopher M and Kim, Kang Ho and Rhoads, J Marc and Liu, Yuying},
  title = {Probiotic Limosilactobacillus reuteri DSM 17938 Changes Foxp3 Deficiency-Induced Dyslipidemia and Chronic Hepatitis in Mice},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16040511}
}
Kostenlos starten →